Page 5 - Regn News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Regn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Regn Today - Breaking & Trending Today
Stiles Financial Services Inc increased its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 12.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,033 shares of the biopharmaceutical company’s stock after purchasing an additional 334 shares during the […] ....
Stiles Financial Services Inc increased its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 12.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,033 shares of the biopharmaceutical company’s stock after purchasing an additional 334 shares during the […] ....
Bleakley Financial Group LLC grew its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 10.6% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 8,977 shares of the biopharmaceutical company’s stock after buying an additional 860 shares during the period. Bleakley Financial Group LLC’s holdings in Regeneron Pharmaceuticals were worth […] ....
Valley National Advisers Inc. increased its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,394 shares of the biopharmaceutical company’s stock after acquiring an additional 24 shares during the period. Valley […] ....
Valley National Advisers Inc. raised its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,394 shares of the biopharmaceutical company’s stock after purchasing an additional 24 shares during the quarter. Valley […] ....